GlobeNewswire

SolarWinds System Management Updates Sharpen Visibility into Physical and Virtual Infrastructure

Dela

Support added for leading all-flash arrays from Dell EMC, HPE Nimble Storage, INFINIDAT and IBM

New functionality creates clear view of server interactions within business applications

AUSTIN, Texas, March 14, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced a pair of product updates that offer broader and deeper performance monitoring capabilities across physical and virtual infrastructures, particularly in hybrid environments. The newest version of SolarWinds®  Storage Resource Monitor (SRM) extends support to a wider range of leading all-flash arrays (AFAs), while the latest update to Server & Application Monitor (SAM) permits deeper visibility into interactions between a set of servers running critical business applications.

"Finding clarity through the haze of complexity is vital to successfully keep today's heterogeneous and distributed IT environments running smoothly," said Christoph Pfister, executive vice president of products, SolarWinds. "With support for more leading-edge storage vendor solutions and deeper visibility into the connection between critical infrastructure resources, our system management updates give IT professionals more powerful tools to overcome complexity and optimize performance in their diverse worlds."

Combined, the two updates arm IT professionals with the broad system management, monitoring, alerting, and reporting functionality needed to optimize performance in hybrid environments, across an even broader mix of systems and vendors.

"The latest versions of SRM and SAM are giving us even more flexibility to deploy new technologies, as well as deeper visibility across our servers and applications," said Jeremy Mayfield, IT director, American Cement Company, a leading cement producer based in Sumterville, Fla. "In particular, the new SRM support for all-flash storage, particularly HPE Nimble, will give us a wider set of options for deploying hyper-converged infrastructure.  The new application dependency capabilities in SAM allow us to see more performance data, enabling us to fix issues more quickly and reduce mean time to repair."

All-Flash Array Support for Mid-Market and Enterprise Customers with Storage Resource Monitor (SRM) 6.6

Built on the SolarWinds Orion® Platform , the latest version of SolarWinds SRM (version 6.6) now supports HPE® Nimble Storage®, Dell® EMC® Unity, INFINIDAT® InfiniBox®, and IBM® AIX® FlashSystem 9000 all-flash arrays (AFAs). With this extended support, SRM 6.6 enables resource monitoring across an even wider mix of infrastructures in multi-vendor environments to meet the needs of an even broader set of customers, particularly mid-sized companies that adopt solutions from HPE Nimble Storage, Dell EMC Unity, INFINIDAT, and IBM. 

SRM's data integration with other SolarWinds products, including Virtualization Manager (VMAN) and Server & Application Monitor (SAM) through the Orion Platform, allows for end-to-end relationship mapping from application and virtualization through storage.

Visualize Critical Application Dependencies with Server & Application Monitor (SAM) 6.6

SolarWinds SAM 6.6 offers end-to-end visibility and performance monitoring of server and applications across multiple data centers, remote locations, or the cloud. This latest update includes application dependency functionality that enables customers to automatically discover network-based relationships, between applications and servers, by correlating communications at the application process level.

IT professionals can leverage the new connection details function, a unique capability to visualize server and network metrics of specific application connections within an environment. This function gives users a fast way to visualize data on metrics such as packet loss, latency, network status, and more, thereby creating the opportunity to reduce time required for identification of root causes of application issues. With the latest enhancements, for example, a customer running a large CRM implementation can explore the dependency between its underlying database servers and associated web servers to pinpoint any performance degradation, or other issues, more efficiently.

SAM 6.6 also features a new SolarWinds Orion Agent for IBM AIX, bringing the company's powerful and affordable monitoring features to customers with IBM AIX-powered systems in their infrastructures.

Pricing and Availability

SolarWinds SRM pricing starts at $2,935* for 25 disks, including the first year of maintenance. SolarWinds SAM pricing starts at $2,995* for 150 monitors, including the first year of maintenance.

For more information, including a downloadable, free 30-day evaluation of SRM or SAM, visit the SolarWinds website , or call 866.530.8100.

*Prices as of March 14, 2018 in US Dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Storage Resource Monitor
Server & Application Monitor

Connect with SolarWinds

About SolarWinds 
SolarWinds provides powerful and affordable IT management software to customers worldwide from Fortune 500® enterprises to small businesses, government agencies and educational institutions. We are committed to focusing exclusively on IT Pros, and strive to eliminate the complexity that they have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address all key areas of the infrastructure from on premises to the Cloud. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com .

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks  are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks) of their respective companies.

© 2018 SolarWinds Worldwide, LLC.  All rights reserved.

MEDIA CONTACTS:
Nicole Fachet                                                                                          
Text100                                                                                                   
Phone: 212.871.3950                                                                              
NicoleF@text100.com                                                                           

Mark Stanton
SolarWinds
Phone: 512.682.9692
pr@solarwinds.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6c5d65ff-4cd6-4cb2-9259-142a824df601




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum